CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Investors that a Securities Fraud Class Action Lawsuit Has Been Filed Against AbbVie, Inc. Pharmaceutical Investing
AUPH INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need Pharmaceutical Investing
CLASS ACTION UPDATE for ABBV, NTRA and OKTA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
ABBV LOSS ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action - ABBV Pharmaceutical Investing
AbbVie Showcases its Leadership in Rheumatology Research with New Data Across Multiple Inflammatory Joint Diseases at the EULAR 2022 Congress Pharmaceutical Investing
Knight Therapeutics Enters into Exclusive License and Supply Agreements with Rigel Pharmaceuticals to Commercialize Fostamatinib in Latin America Pharmaceutical Investing
Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis Life Science Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VLTA, AUPH and PEGA Pharmaceutical Investing
LAWSUITS FILED AGAINST LCID, AUPH and BKKT - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ABBV, IRNT and BKKT Pharmaceutical Investing
